These findings provide new insights into the role of CAIX/PFKFB4 and the molecular mechanism involved in the progression of cervical cancer, suggesting that CAIX/PFKFB4 could be a potential diagnostic and therapeutic target in cervical cancer. This evidence concerns the gene CA9 and cervical cancer.